Figure 1From: Revisiting the cost-effectiveness of universal HPV-vaccination in Denmark accounting for all potentially vaccine preventable HPV-related diseases in males and females Cost-effectiveness acceptability curves: proportion of simulations that would be cost-effective given different thresholds values of cost per QALY gained. It should be noted that this multi-way sensitivity analysis did not address all sources of uncertainty as some parameters were not included.Back to article page